Additional file 2: of Low serum gastrin associated with ER+ breast cancer development via inactivation of CCKBR/ERK/P65 signaling

Figure S1. Expression of ER, PR, HER2 in 5 primary BC samples. Three primary BC samples were clinically defined as ER+/PR+/HER2− by IHC. Two primary BC samples were clinically defined as TNBC and ER−/PR−/HER2+ by IHC. Case1:HER2−ER+PR+ Case2:HER2−ER+PR+ Case3:HER2−ER+PR+ Case4:HER2−ER−PR−(TNBC) Case...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Meng, Li-Li, Jing-Long Wang, Xu, Shu-Ping, Zu, Li-Dong, Yan, Zhao-Wen, Zhang, Jian-Bing, Han, Ya-Qin, Fu, Guo-Hui
Format:	Bild
Sprache:	eng
Schlagworte:	Biotechnology Cancer Cell Biology Chemical Sciences not elsewhere classified Computational Biology Developmental Biology Ecology Environmental Sciences not elsewhere classified FOS: Biological sciences FOS: Chemical sciences FOS: Earth and related environmental sciences FOS: Mathematics Genetics Mathematical Sciences not elsewhere classified Molecular Biology Plant Biology
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Figure S1. Expression of ER, PR, HER2 in 5 primary BC samples. Three primary BC samples were clinically defined as ER+/PR+/HER2− by IHC. Two primary BC samples were clinically defined as TNBC and ER−/PR−/HER2+ by IHC. Case1:HER2−ER+PR+ Case2:HER2−ER+PR+ Case3:HER2−ER+PR+ Case4:HER2−ER−PR−(TNBC) Case5: HER2+ER−PR− Scale bar: 50 μm. (TIF 3702 kb)
DOI:	10.6084/m9.figshare.6978173